Zimmer Biomet

From Wikipedia, the free encyclopedia
  (Redirected from Zimmer Holdings)
Jump to: navigation, search
Zimmer Biomet Holdings, Inc.
Founded Warsaw, Indiana, U.S. (1927)
Founder Justin O. Zimmer
Headquarters Warsaw, Indiana, USA
Key people
David C Dvorak (President/CEO)
Revenue US$ 4.62 billion (2013)[1]
Website www.zimmerbiomet.com

Zimmer Biomet (NYSEZBH) is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

In 2001 Zimmer was spun off from Bristol-Myers Squibb and begins trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the Company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the Company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.

The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.

Products[edit]

Zimmer designs, develops, manufactures and markets orthopaedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints and dental prostheses. Zimmer has operations in more than 25 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Deutschland, India, Ireland, Israel, Italy, Japan, Latin America, Nedherland, Brasil, Portugal, Russia, South Africa, Spain etc. and sells products in more than 100 countries.[2]

In British English, a "Zimmer frame" has become a genericized trademark term for a walking frame.

Corporate history[edit]

On 24 April 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion.[3] In October 2014 however, it was announced that the EU’s antitrust regulators had opened an extensive investigation into Zimmer’s bid for Biomet due to concern that it would substantially lessen competition in certain markets. A decision was announced to be made on 16 February 2015.[4]and on June 24, 2015, Zimmer completed its acquisition of Biomet forming Zimmer Biomet Holdings.

Company data[edit]

Zimmer's 2013 sales were approximately $4.62 billion. The company is supported by the efforts of approximately 9,000 employees worldwide.

Leadership[edit]

Zimmer Biomet leadership includes the following individuals:[5]

  • David C. Dvorak, President and CEO
  • Robin T. Barney, Senior Vice President, Global Operations and Logistics
  • Audrey Beckman, Senior Vice President, Strategic Quality Initiatives
  • Tony Collins, Vice President, Corporate Controller and Chief Accounting Officer
  • Derek Davis, Vice President, Global Integration
  • William P. (Bill) Fisher, Senior Vice President, Global Human Resources
  • Daniel P. Florin, Senior Vice President and Chief Financial Officer
  • Adam R. Johnson, Group President, Spine, Bone Healing, Dental, CMF and Thoracic
  • Stuart G. Kleopfer, President, Americas
  • David J. Kunz, Vice President, Global Quality, Clinical and Regulatory Affairs
  • Katarzyna Mazur-Hofsaess, M.D., Ph.D., President, Europe, Middle East and Africa
  • David A. Nolan Jr., Group President, Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle
  • Chad Phipps, Senior Vice President, General Counsel and Secretary
  • Daniel E. Williamson, Group President, Joint Reconstruction
  • Sang Yi, President, Asia Pacific

References[edit]

  1. ^ "2013 Annual Report" (PDF). 
  2. ^ Simon, Hermann, Hidden Champions of the 21st Century: Success Strategies of unknown World Market Leaders, London: Springer, 2009, ISBN 978-0-387-98147-5
  3. ^ Michelle Fay Cortez. "Zimmer to Buy Biomet for $13.4 Billion Adding Orthopedics". Bloomberg.com. 
  4. ^ "EU regulators open extensive probe into Zimmer, Biomet deal" (Press release). Reuters. 3 October 2014. 
  5. ^ "Zimmer Biomet Leadership Team". 

External links[edit]